Natasha Loder
banner
natashaloder.bsky.social
Natasha Loder
@natashaloder.bsky.social
Health Editor, The Economist.

#Science #medicine #health, aspiring optimist, omnivorous information eater, mother of dragons.

Free words at: Overmatter.substack.com
Pinned
The dream of enhancing humanity is becoming a reality, with investments pouring into the human enhancement industry, aiming to make us stronger, smarter, and longer-lived. Notable investors like Christian Angermayer, Peter Thiel, Elon Musk are at the forefront #HumanEnhancement #TechRevolution
Reposted by Natasha Loder
Interessante lezing over de toekomst van de wetenschapsjournalistiek en de rol van AI:
A few thoughts on the future of science journalism from a talk I gave recently--at UCL for the American Association of Science Journalism.

open.substack.com/pub/overmatt...
From Print to Prompts
What the past tells us about the future of science journalism
open.substack.com
November 17, 2025 at 10:34 AM
A few thoughts on the future of science journalism from a talk I gave recently--at UCL for the American Association of Science Journalism.

open.substack.com/pub/overmatt...
From Print to Prompts
What the past tells us about the future of science journalism
open.substack.com
November 17, 2025 at 10:28 AM
Do women need testosterone supplements? Sometimes, yes. www.economist.com/science-and-...
Do women need testosterone supplements?
It can be helpful in some cases, but it’s no fountain of youth
www.economist.com
November 14, 2025 at 3:49 PM
Great to see this by @michaelsavage which recognises the key role of one journalist-- @deb_cohen--in breaking the key transgender medicine stories at the BBC. Deb is one of the bravest journalists I know; without her would Cass have even happened?

www.theguardian.com/media/2025/n...
BBC reporter who covered gender dysphoria questions claim of ‘systemic bias’
Deborah Cohen says she is not aware of any attempts within corporation to stop or shape her reporting on trans issues
www.theguardian.com
November 13, 2025 at 5:10 PM
I just swore at Google Gemini when it was being unhelpful and it refused to answer until I rephrased my request. #passiveaggressiveAI
November 8, 2025 at 11:25 AM
My theory about why #notgrafs exist is that shortly before a journalist is due to file his news piece to deadline he speaks to someone who completely contradicts the premise of the story. So rather than spiking the story, the #notgraf is inserted at the end of the story.
See in the wild again the #notgraf!

This is the part of a news tory, about 3/4 of the way in, that undermines the entire premise of the piece ahead of it. This is a classic...

www.telegraph.co.uk/global-healt...
Access Restricted
www.telegraph.co.uk
November 6, 2025 at 2:17 PM
See in the wild again the #notgraf!

This is the part of a news tory, about 3/4 of the way in, that undermines the entire premise of the piece ahead of it. This is a classic...

www.telegraph.co.uk/global-healt...
Access Restricted
www.telegraph.co.uk
November 6, 2025 at 2:14 PM
One of my latest posts on Overmatter, my free Substack.
A few thoughts on the future of science journalism--from a talk I gave recently at UCL for the American Association of Science Journalism.

open.substack.com/pub/overmatt...
From Print to Prompts
What the past tells us about the future of science journalism
open.substack.com
November 3, 2025 at 9:52 PM
Reposted by Natasha Loder
The east wing of science is being demolished by the new administration.

Read my Substack about a new documentary I’ve made with Sandra Kanthal about the impact on biomedical scientists at Harvard.

open.substack.com/pub/overmatt...
Science under siege
A new audio documentary from The Economist
open.substack.com
October 29, 2025 at 5:11 PM
A few thoughts on the future of science journalism from a talk I gave recently--at UCL for the American Association of Science Journalism.

open.substack.com/pub/overmatt...
From Print to Prompts
What the past tells us about the future of science journalism
open.substack.com
October 29, 2025 at 5:15 PM
The east wing of science is being demolished by the new administration.

Read my Substack about a new documentary I’ve made with Sandra Kanthal about the impact on biomedical scientists at Harvard.

open.substack.com/pub/overmatt...
Science under siege
A new audio documentary from The Economist
open.substack.com
October 29, 2025 at 5:11 PM
A few thoughts on the future of science journalism from a talk I gave recently--at UCL for the American Association of Science Journalism.

open.substack.com/pub/overmatt...
From Print to Prompts
What the past tells us about the future of science journalism
open.substack.com
October 28, 2025 at 3:13 PM
Reposted by Natasha Loder
The new administration is demolishing the east and west wings of medical research. Find out more in my podcast documentary for The Weekend Intelligence with Sandra Kanthal
“We went from one day up in the stars and then boom, no funding, and no way to move forward,” Breakthrough Prize-winner Alberto Ascherio tells “The Weekend Intelligence”.

Listen to the podcast to hear more from the scientists under siege in America
Science under siege
A chill political wind is rattling America’s ivory towers. What does it mean for research?
econ.st
October 26, 2025 at 1:44 PM
Our new cat overlords are plotting against us..
The best back story
October 26, 2025 at 5:21 PM
Reposted by Natasha Loder
A few thoughts on the future of science journalism--from a talk I gave recently at UCL for the American Association of Science Journalism.

open.substack.com/pub/overmatt...
From Print to Prompts
What the past tells us about the future of science journalism
open.substack.com
October 26, 2025 at 4:30 PM
A few thoughts on the future of science journalism--from a talk I gave recently at UCL for the American Association of Science Journalism.

open.substack.com/pub/overmatt...
From Print to Prompts
What the past tells us about the future of science journalism
open.substack.com
October 26, 2025 at 4:30 PM
The new administration is demolishing the east and west wings of medical research. Find out more in my podcast documentary for The Weekend Intelligence with Sandra Kanthal
“We went from one day up in the stars and then boom, no funding, and no way to move forward,” Breakthrough Prize-winner Alberto Ascherio tells “The Weekend Intelligence”.

Listen to the podcast to hear more from the scientists under siege in America
Science under siege
A chill political wind is rattling America’s ivory towers. What does it mean for research?
econ.st
October 26, 2025 at 1:44 PM
I have just invented the best out of office reply for Halloween ever. Go on guess...
October 24, 2025 at 6:53 PM
Amazing and intriguing story about mRNA covid vaccines potentially enhancing the response to immunotherapy in cancer.

www.statnews.com/2025/10/19/m...
mRNA Covid shots may boost the effects of certain cancer treatments, study suggests
The potential reasons that a Covid vaccine would help treat cancer are intriguing.
www.statnews.com
October 21, 2025 at 8:53 AM
Reposted by Natasha Loder
What does the future hold for science journalism—and who gets to shape it? @economist.com health editor and 2024 AAAS Kavli Gold Award-winner @natashaloder.bsky.social will give the second AAAS Kavli Fall Lecture Series talk at @stsucl.bsky.social tomorrow, Oct. 10. Register: http://bit.ly/4n2X5UX
October 14, 2025 at 6:30 PM
Lovely technical round up of the frontiers of immuno-oncology
Really encouraging progress in cancer vaccine work. Bonus editorial at the end:
Progress in Cancer Vaccines (Really)
www.science.org
October 14, 2025 at 9:38 AM
Am I allowed to posit that what Trump has managed to accomplish so far in the Middle East is actually pretty remarkable?
October 14, 2025 at 9:34 AM
If China manages to crack the problem of making cheap and effective gene therapies and America doesn't crack the problem of paying what the market will bear for gene therapies it will just get ripped off.
“We will show the world that there is a better, more responsible, and economically more sensible way of drug development,” -- Chinese biotech offering a low-cost version of a gene therapy that saves the lives of small children but at a cost of $2m

endpoints.news/chinese-biot...
In China, a low-cost push to rival a life-saving, $2M medicine
Indian veterinarian Nirnay Murthy sought Lantu Biopharma's experimental gene therapy for his son's spinal muscular atrophy after being unable to afford Novartis's $2.1M Zolgensma treatment.
endpoints.news
October 10, 2025 at 9:44 AM
“We will show the world that there is a better, more responsible, and economically more sensible way of drug development,” -- Chinese biotech offering a low-cost version of a gene therapy that saves the lives of small children but at a cost of $2m

endpoints.news/chinese-biot...
In China, a low-cost push to rival a life-saving, $2M medicine
Indian veterinarian Nirnay Murthy sought Lantu Biopharma's experimental gene therapy for his son's spinal muscular atrophy after being unable to afford Novartis's $2.1M Zolgensma treatment.
endpoints.news
October 10, 2025 at 9:36 AM
In this talk I'll reflect back on what journalism's past tells us about the future of science journalism. I'll also talk about my long love affair with journalism, and how to get a bikini wax on expenses. Do come and join us, and let us debate the future.
October 3, 2025 at 10:07 AM